profit from every $100 of sales.
$0$100
Fresenius Medical Care AG & Co. KGaA
$22.74-0.92% today
-4.1% in 1 year
1-year low $20.191-year high $25.70
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $10.80 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Fresenius Medical Care AG & Co. KGaA sold, what it kept, and what it did with the cash.
Sales went from €19.4 billion in 2022 to €19.6 billion in 2025, with €978 million of profit last year.
SalesProfit
Fresenius Medical Care AG & Co. KGaA handed back 57% of the cash it generated last year.
Buybacks €585M€423M
Free cash flow 2025€1.8B
Bought back its own shares€585M
Paid as dividends€423M
Cash vs. debt€1.6B vs. €10.8B
Fresenius Medical Care AG & Co. KGaA vs. similar companies
Fresenius Medical Care AG & Co. KGaA grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 10.8× · Cheap | ||
 Tenet Healthcare | 16.4× · Fair price | ||
 Solventum | 9.8× · Cheap | ||
 Encompass Health | 24.7× · Fair price | ||
 DaVita | 15.1× · Fair price |
AI analysis
An AI analyst reads Fresenius Medical Care AG & Co. KGaA's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 19,398 | 19,454 | 19,336 | 19,628 | |
| 4,894 | 4,925 | 4,757 | 5,029 | |
| 1,455 | 1,477 | 1,467 | 1,827 | |
| 3,418 | 3,210 | 3,206 | 3,397 | |
| 673 | 499 | 538 | 978 | |
| 1.15 | 0.85 | 0.92 | 1.68 | |
| 25.2% | 25.3% | 24.6% | 25.6% | |
| 7.5% | 7.6% | 7.6% | 9.3% | |
| 3.5% | 2.6% | 2.8% | 5.0% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 35,754 | 33,930 | 33,567 | 31,002 |
| Cash | 1,274 | 1,377 | 1,151 | 1,583 |
| Total debt | 13,192 | 12,050 | 10,979 | 10,796 |
| Total liabilities | 20,305 | 19,103 | 17,798 | 16,720 |
| 13,989 | 13,620 | 14,577 | 13,310 | |
| 586 | 587 | 587 | 582 | |
| 4.6% | 4.5% | 4.5% | 6.2% | |
| 4.8% | 3.7% | 3.7% | 7.4% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2,167 | 2,629 | 2,386 | 2,681 | |
| 724 | 685 | 699 | 915 | |
| 1,443 | 1,944 | 1,687 | 1,766 | |
| Dividends paid | 396 | 329 | 349 | 423 |
| 0 | 0 | 0 | 585 | |
| – | – | – | – |
Valuation
- 10.8×
- 11.1×
- 0.80
- 0.8×
- 0.5×
- 6.0×
- 5.8×
- 16.7%
- 9.3%
- 4.0%
Profitability
- 25.6%
- 9.3%
- 5.0%
- 17.9%
- 5.5%
- 2.8%
- 7.0%
- 3.0%
- 7.6%
- 1.4%
Growth
- +0.4%
- +13.5%
- +0.5%
- +2.9%
- −16.0%
Financial health
- 3.0×
- 0.83
- 35.0%
- 5.2×
- 1.20
- 0.86
- 0.62
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 48%of 945
Top 49%of 870
Top 11%of 559
Bottom 16%of 867
Top 3%of 986
What analysts expect
- Average price target
- $28.00
- Range
- $28.00 – $28.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 5, 2026 | 0.53 | 0.59 | −10.2% |
| Feb 24, 2026 | 0.83 | 0.65 | +28.3% |
| Nov 4, 2025 | 0.64 | 0.59 | +8.5% |
| Aug 5, 2025 | 0.52 | 0.50 | +4.0% |
| May 6, 2025 | 0.44 | 0.43 | +2.3% |
| Feb 25, 2025 | 0.48 | 0.41 | +17.1% |
| Nov 5, 2024 | 0.45 | 0.38 | +18.4% |
| Jul 30, 2024 | 0.38 | 0.38 | +0.0% |
4.0%of the share price, paid each year
On $1,000 invested$40a year at today's yield, before tax
+2.9%2020 to 2025
Raised2 yearsin a row, in our data
Paid per share, each year
$0.44 in 2015 → $0.82 in 2025
How safe it looks
43.2% of its profit
Room to growStretchedMore than it earns: 23.9%
News
Boeing wins $156M Navy contract for P-8A engine kits, FMS customersSeeking Alpha · Aug 20, 2026The newest story we have is from Aug 20, 2026.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
56No pass
Benjamin Graham
79Pass
Philip Fisher
48No pass
Peter Lynch
56No pass
Joel Greenblatt
44No pass
Charlie Munger
34No pass
Terry Smith
34No pass
Questions about Fresenius Medical Care AG & Co. KGaA
Is Fresenius Medical Care AG & Co. KGaA a good stock to buy?
A business with weak numbers, and the price looks low. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Fresenius Medical Care AG & Co. KGaA AI analysis
What does Fresenius Medical Care AG & Co. KGaA do?
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It is in Medical - Care Facilities, based in Bad Homburg, Germany, with 108,165 employees.
Does Fresenius Medical Care AG & Co. KGaA pay a dividend?
Yes. At today's price the dividend is 4.0% a year, about 43% of its yearly profit. In 2025 it paid out $423 million in dividends.
Is Fresenius Medical Care AG & Co. KGaA stock halal?
No. Fresenius Medical Care AG & Co. KGaA does not pass our halal screen: its debt is 56% of its market value, at or above the 33% limit. How we check
How has Fresenius Medical Care AG & Co. KGaA stock done over the past year?
Down 4.1% over the past twelve months, to $22.74. It traded between $20.19 and $25.70 and is 11.5% below its high.
Who are Fresenius Medical Care AG & Co. KGaA's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Solventum, Encompass Health and DaVita. The peers table on this page compares their profit, growth and price with Fresenius Medical Care AG & Co. KGaA's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.